Last $7.09 USD
Change Today -0.205 / -2.81%
Volume 221.8K
MACK On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 10:36 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael E. Porter Ph.D.

Strategy Advisor, Director, Chairman of Corporate Governance & Nominating Committee and Member of Executive Committee, Merrimack Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 68 board members in 9 different organizations across 9 different industries.

See Board Relationships
67$143,744

Background*

Prof. Michael E. Porter, Ph.D., is an Advisor at Hamilton Investment Partners, LLC. He has been a Strategy Advisor of Merrimack Pharmaceuticals, Inc. since 1999. Prof. Porter is the Bishop William Lawrence University Professor at Harvard Business School. He serves as an Advisor to business, government and the social sector. Prof. Porter also served as the Chief Executive Officer at Initiative for a Competitive Inner City. He served as an Advisor to both International ...

Read Full Background

Corporate Headquarters*

One Kendall Square
Cambridge, Massachusetts 02139

United States

Phone: 617-441-1000
Fax: 617-491-1386

Board Members Memberships*

Prior
Founder and Chairman of the Board
Former Director
1991-Present
Director
1993-Present
Director
1995-Present
Director and Chairman of Corporate Development Committee
1995-N/A
Former Director
1997-N/A
Director
1997-N/A
Former Director
2000-N/A
Former Director
2001-2012
Former Director, Member of Nominating & Corporate Governance Committee and Member of Strategy & Finance Committee
2006-N/A
Independent Director and Chairman of Strategy Committee
2010-Present
Strategy Advisor, Director, Chairman of Corporate Governance & Nominating Committee and Member of Executive Committee
2013-Present
Director and Chairperson of Strategy & Business Development Committee

Education*

PhD 1973
Harvard University
MBA 1971
Harvard Business School
BSE 1969
Princeton University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$51,000
Total Calculated Compensation$143,744
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MACK:US $7.09 USD -0.205

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERRIMACK PHARMACEUTICALS IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.